Search results
Results from the WOW.Com Content Network
The most common side effects include nausea (feeling sick), headache, diarrhoea and vomiting. [4] These side effects were generally of mild or moderate severity. [4] Tedizolid was approved for medical use in the United States in June 2014, [6] [7] and for medical use in the European Union in March 2015. [4]
Additionally, Tedizolid was shown to have fewer treatment-related side effects than linezolid and significantly fewer GI side effects. [6] Trius was planning the second Phase 2 trial and expects to report results around the end of Q1 2013 and planned to submit an NDA to the FDA for the drug in the second half of 2013. [7]
Possible side effects [4] Mechanism of action Aminoglycosides; Amikacin: Amikin: Infections caused by Gram-negative bacteria, such as Escherichia coli and Klebsiella particularly Pseudomonas aeruginosa. Effective against aerobic bacteria (not obligate/facultative anaerobes) and tularemia. All aminoglycosides are ineffective when taken orally as ...
Cubist Pharmaceuticals to Acquire Trius Therapeutics Adds Highly Complementary, Late-Stage Antibiotic Candidate, Tedizolid, and Bolsters Cubist's Global Leadership in the Acute Care/Hospital ...
Tedizolid mops the floor with its competition. The biotech sector can occasionally throw a curveball at investors. For Trius Therapeutics shareholders, they were staring at a meaty fastball right ...
This combination drug, which is made up of a statin -- Pfizer's now generic Lipitor -- and Merck's cholesterol absorption inhibitor Zetia, delivered a far bigger effect on reducing LDL-cholesterol ...
Linezolid is an antibiotic used for the treatment of infections caused by Gram-positive bacteria that are resistant to other antibiotics. [9] [10] Linezolid is active against most Gram-positive bacteria that cause disease, including streptococci, vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA).
Women are twice as likely to have an eating disorder in their 40s as to have breast cancer, but midlife eating disorders are under-researched and overlooked.